Kraig Biocraft Laboratories to be Featured in Upcoming Documentary Series on Combating Terrorism
Kraig Labs opens R&D headquarters to media for the first time
ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24KBLB&src=ctag” target=”_blank”gt;$KBLBlt;/agt; lt;a href=”https://twitter.com/hashtag/KBLB?src=hash” target=”_blank”gt;#KBLBlt;/agt;–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading
developer of spider silk based fibers, announces today that its
recombinant spider silk technology will be featured in a documentary
focused on combating terrorism. The Company opened the doors of its R&D
headquarters, for the first time to the media, to host a French
documentary film crew and provided them with access to the process of
creating its incredible spider silk technologies.
Tougher and more flexible than competing materials, spider silk offers
the promise of increased protection, comfort, and mobility in protective
textile applications. In addition to this documentary, the Company has
been covered by numerous media outlets, including the following T.EVO,
Textile Evolution, article; https://www.tevonews.com/fibres-yarns-news/2026-polartec-figureheads-discuss-kraig-labs-silkworm-solution.
“Our team is incredibly proud of the work we do here and the impact that
our Company is already making in these important markets,” said COO Jon
Rice. “It was a pleasure to be able to share the results of our efforts
and to showcase this amazing technology, along with its potential to
disrupt the protective textile and related markets.”
The series is planned to air in the fall of 2019. Although the footage
was shot at Kraig Labs’ R&D headquarters in Michigan, the Company
continues to focus its efforts on scaling up its production operations,
through its subsidiary, Prodigy Textiles Ltd., in Asia. By utilizing the
existing global silk infrastructure and Kraig Labs’ engineered silkworm
technology, the Company is set to meet cost and volume metrics,
previously thought to be impossible, in the commercialization of spider
silk for these lifesaving applications in protective textiles.
To view the most recent news from Kraig Labs and/or to sign up for
Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global textile
industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and
expectations other than historical facts are “forward-looking
statements.” These statements are made on the basis of management’s
current views and assumptions. As a result, there can be no assurance
that management’s expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such
as “believes,” “plans,” “expects,” “anticipates,” “foresees,”
“estimated,” “hopes,” “if,” “develops,” “researching,” “research,”
“pilot,” “potential,” “could” or other words or phrases of similar
import. Forward looking statements include descriptions of the Company’s
business strategy, outlook, objectives, plans, intentions and goals. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
those in forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy any
security.
Contacts
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com